Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Ebert

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
Cancer Letters|March 10, 2024
Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interactionPhilip Weidner, Daniel Saar, Michaela Söhn, et al.
American Journal of Epidemiology|December 29, 2007
Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC reviewStefania Boccia, Rayjean Hung, Gualtiero Ricciardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal CancerAdam Lafferty, Alice C O'Farrell, Giorgia Migliardi, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2025
ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signallingYujia Li, Chenjun Huang, Weiguo Fan, et al.
Journal of Hepatology|February 4, 2015
Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensationHai Li, Qiang Xia, Bo Zeng, et al.
Hepatology (Baltimore, Md.)|August 26, 2021
Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failureTao Lin, Shanshan Wang, Stefan Munker, et al.
Molecular and Cellular Endocrinology|April 21, 2023
Intestinal BMP-9 locally upregulates FGF19 and is down-regulated in obese patients with diabetesStephan Drexler, Chen Cai, Anna-Lena Hartmann, et al.
Hepatology (Baltimore, Md.)|November 3, 2025
Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failureTao Lin, Shanshan Wang, Stefan Munker, et al.
Nature Communications|October 7, 2018
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapyDominiek Smeets, Ian S Miller, Darran P O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2018
Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With BevacizumabErik van Dijk, Hedde D Biesma, Martijn Cordes, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Cancer Letters|March 10, 2024
Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interactionPhilip Weidner, Daniel Saar, Michaela Söhn, et al.
American Journal of Epidemiology|December 29, 2007
Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC reviewStefania Boccia, Rayjean Hung, Gualtiero Ricciardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal CancerAdam Lafferty, Alice C O'Farrell, Giorgia Migliardi, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2025
ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signallingYujia Li, Chenjun Huang, Weiguo Fan, et al.
Journal of Hepatology|February 4, 2015
Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensationHai Li, Qiang Xia, Bo Zeng, et al.
Hepatology (Baltimore, Md.)|August 26, 2021
Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failureTao Lin, Shanshan Wang, Stefan Munker, et al.
Molecular and Cellular Endocrinology|April 21, 2023
Intestinal BMP-9 locally upregulates FGF19 and is down-regulated in obese patients with diabetesStephan Drexler, Chen Cai, Anna-Lena Hartmann, et al.
Hepatology (Baltimore, Md.)|November 3, 2025
Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failureTao Lin, Shanshan Wang, Stefan Munker, et al.
Nature Communications|October 7, 2018
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapyDominiek Smeets, Ian S Miller, Darran P O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2018
Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With BevacizumabErik van Dijk, Hedde D Biesma, Martijn Cordes, et al.
Pageof 28